Genialis and Debiopharm expand collaboration to develop RNA-based predictive biomarkers for DDR therapies, advancing precision oncology.

This extension builds on a 2024 agreement to define and discover biomarkers within the DNA damage response (DDR) biological space to predict the clinical benefit of one or more drugs in Debiopharm ...

Most people associate sunburns with DNA damage -- it's what we've been taught in textbooks and by dermatologists for years.

A research team from the University of California, Irvine has revealed a previously unknown mechanism that triggers an inflammatory immune response ... cells react to DNA damage could lead to ...

1The University of Texas MD Anderson Cancer Center, Houston, TX. Search for other works by this author on: ...